|
1
|
Theilig F, Kriz W, Jerichow T, et al:
Abrogation of protein uptake through megalin-deficient proximal
tubules does not safeguard against tubulointerstitial injury. J Am
Soc Nephrol. 18:1824–1834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chassin C, Goujon JM, Darche S, et al:
Renal collecting duct epithelial cells react to
pyelonephritis-associated Escherichia coli by activating
distinct TLR4-dependent and -independent inflammatory pathways. J
Immunol. 177:4773–4784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee HK and Iwasaki A: Innate control of
adaptive immunity: dendritic cells and beyond. Semin Immunol.
19:48–55. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zager RA, Johnson AC, Lund S and
Randolph-Habecker J: Toll-like receptor (TLR4) shedding and
depletion: acute proximal tubular cell responses to hypoxic and
toxic injury. Am J Physiol Renal Physiol. 292:304–312. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar
|
|
7
|
Poltorak A, He X, Smirnova I, et al:
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations
in Tlr4 gene. Science. 282:2085–2088. 1998. View Article : Google Scholar
|
|
8
|
Scherberich JE and Hartinger A: Impact of
Toll-like receptor signalling on urinary tract infection. Int J
Antimicrob Agents. 31:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chowdhury P, Sacks SH and Sheerin NS:
Toll-like receptors TLR2 and TLR4 initiate the innate immune
response of the renal tubular epithelium to bacterial products.
Clin Exp Immunol. 145:346–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palmer SM, Burch LH, Mir S, et al: Donor
polymorphisms in Toll-like receptor-4 influence the development of
rejection after renal transplantation. Clin Transplant. 20:30–36.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Dong X, Wu H, Zhang L and Zhang D:
Progress in studies on pharmacological effect of rhubarb and its
active components. Medical Recapitulate. 1:76–78. 2005.
|
|
12
|
China Pharmacopoeia Committee.
Pharmacopoeia of the People’s Republic of China. (First Division of
2000 ed). China Chemical Industry Press; Beijing: pp. 181999
|
|
13
|
Kwak HJ, Park MJ, Park CM, et al: Emodin
inhibits vascular endothelial growth factor-A-induced angiogenesis
by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer.
118:2711–2720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang R, Wan Q, Zhang Y, et al: Emodin
suppresses interleukin-1beta induced mesangial cells proliferation
and extracellular matrix production via inhibiting P38 MAPK. Life
Sci. 80:2481–2488. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu XL, Wang J, Zhou DW, et al:
Experimental studies on prevention and treatment of
glomerulosclerosis with Centella Asiatica compound and its
mechanism. Chin J Nephrol. 17:199–200. 2001.
|
|
16
|
Zhu XL, Wang YJ, Cheng XX, Tong ML, Chen
HY and Zhang MS: Effects of niaodujing II on cyclin D1, CDK4 in
cultured glomerular mesangial cells in human. Chin J Integr Tradit
West Nephrol. 6:316–318. 2004.
|
|
17
|
Kitano A, Saika S, Yamanaka O, et al:
Emodin suppression of ocular surface inflammatory reaction. Invest
Ophthalmol Vis Sci. 48:5013–5022. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen RF, Shen YC, Huang HS, et al:
Evaluation of the anti-inflammatory and cytotoxic effects of
anthraquinones and anthracenes derivatives in human leucocytes. J
Pharm Pharmacol. 56:915–919. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z, Xia X, Zhang S, Zhang A, Bo W and
Zhou R: Up-regulation of Toll-like receptor 4 was suppressed by
emodin and baicalin in the setting of acute pancreatitis. Biomed
Pharmacother. 63:120–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Springall T, Sheerin NS, Abe K, Holers VM,
Wan H and Sacks SH: Epithelial secretion of C3 promotes
colonization of the upper urinary tract by Escherichia coli.
Nat Med. 7:801–806. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beutler B and Rietschel ET: Innate immune
sensing and its roots: the story of endotoxin. Nat Rev Immunol.
3:169–176. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Achkar TM and Dagher PC: Renal
Toll-like receptors: recent advances and implications for disease.
Nat Clin Pract Nephrol. 2:568–581. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cunningham PN, Wang Y, Guo R, He G and
Quigg RJ: Role of Toll-like receptor 4 in endotoxin-induced acute
renal failure. J Immunol. 172:2629–2635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Säemann MD, Weichhart T, Zeyda M, et al:
Tamm-Horsfall glycoprotein links innate immune cell activation with
adaptive immunity via a Toll-like receptor-4-dependent mechanism. J
Clin Invest. 115:468–475. 2005.
|
|
25
|
Banas MC, Banas B, Hudkins KL, et al: TLR4
links podocytes with the innate immune system to mediate glomerular
injury. J Am Soc Nephrol. 19:704–713. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang B, Ramesh G, Uematsu S, Akira S and
Reeves WB: TLR4 signaling mediates inflammation and tissue injury
in nephrotoxicity. J Am Soc Nephrol. 19:923–932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Huang H, Liu P, et al: Inhibition
of phosphorylation of p38 MAPK involved in the protection of
nephropathy by emodin in diabetic rats. Eur J Pharmacol.
553:297–303. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu G, Ye R and Tan Z: Effect of emodin on
fibroblasts in lupus nephritis. Zhongguo Zhong Xi Yi Jie He Za Zhi.
20:196–198. 2000.PubMed/NCBI
|
|
29
|
Mei XB, Yuan WJ, Zhan FL, Wu H, Zhang XY
and Cui RL: Role of cyclin kinase inhibitor p27 in inhibition of
emodin on mesangial cell proliferation induced by tumor necrosis
factor-alpha. Zhong Xi Yi Jie He Xue Bao. 2:120–122. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yeboah MM, Xue X, Duan B, Ochani M, Tracey
KJ, Susin M and Metz CN: Cholinergic agonists attenuate renal
ischemia-reperfusion injury in rats. Kidney Int. 74:62–69. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ando M, Shibuya A, Tsuchiya K, Akiba T and
Nitta K: Reduced expression of Toll-like receptor 4 contributes to
impaired cytokine response of monocytes in uremic patients. Kidney
Int. 70:358–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leung JC, Tang SC, Chan LY, Chan WL and
Lai KN: Synthesis of TNF-alpha by mesangial cells cultured with
polymeric anionic IgA - role of MAPK and NF-kappaB. Nephrol Dial
Transplant. 23:72–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Navarro JF, Milena FJ, Mora C, León C and
García J: Renal pro-inflammatory cytokine gene expression in
diabetic nephropathy: effect of angiotensin-converting enzyme
inhibition and pentoxifylline administration. Am J Nephrol.
26:562–570. 2006. View Article : Google Scholar
|
|
34
|
Johnson GB, Brunn GJ and Platt JL: Cutting
edge: an endogenous pathway to systemic inflammatory response
syndrome (SIRS)-like reactions through Toll-like receptor-4. J
Immunol. 172:20–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ogawa Y, Tasaka S, Yamada W, Saito F,
Hasegawa N, Miyasho T and Ishizaka A: Role of toll-like receptor 4
in hyperoxia-induced lung inflammation in mice. Inflamm Res.
56:334–338. 2007. View Article : Google Scholar : PubMed/NCBI
|
